Type 2 Diabetes Medication Linked to Pancreatic Cancer

Posted on Thursday, May 10, 2018

Provost Umphrey has recently started considering cases where those taking medication for Type 2 Diabetes have developed pancreatic cancer or pancreatitis. Type 2 Diabetes accounts for 90-95% of all diabetic diagnosed cases in adults. There are over 29 million individuals who have been diagnosed with diabetes in the U.S. Diabetic medication is commonly used to manage Type 2 Diabetes.

Those with Type 2 Diabetes who are taking the medications listed below are thought to be at an increased risk of developing pancreatic cancer and pancreatitis.

  • BYETTA – a twice-daily injection that imitates the effect of glucagon-like peptide-1, which is a hormone that increases the production of insulin when the blood sugar of an individual is high.
  • JANUVIA – a once-daily pill that is used to help lower blood glucose levels. It helps increase insulin production by the pancreas and decrease the amount of sugar produced by the liver.
  • JANUMET – once a week injection that has the same ingredients as Byetta but longer lasting.
  • VICTOZA – Once daily injection that has same ingredients of Byetta. Christopher T. Kirchmer leads the charge for pharmaceutical and medical device product liability at Provost Umphrey. During his career, he has represented those affected by defective hip implants, hormone replacement therapy, Xarelto, Mirena, transvaginal mesh, and more. Most recently, Kirchmer was named to the Plaintiffs Steering Committees for both the Bard IVC Filter litigation and the Cook IVC Filter litigation.If you or a loved one has suffered or been diagnosed with pancreatic cancer due to the use of Byetta, Januvia, Janumet, or Victoza please contact our firm today for a free consultation on your potential lawsuit.
This entry was posted in no categories.

You must be logged in to post comments.